In a court fight between engineering firm Clough and its former joint venture partner Elecnor, a judge has questioned Elecnor’s “extremely inconvenient” bid to send Clough’s $54 million cross-claim to arbitration in Singapore.
Insurer Marsh has fired off a cross-claim against Swiss bank UBS in several cases brought over Greensill’s $1.7 billion collapse.
Newcastle council’s concerns about the street appeal of a Woolworths development have been brushed aside, with a court finding that reasonable minds may differ on the question of ‘high visual quality.’ On Tuesday, Justice John Robson of the NSW Land and Environment Court granted the development approval sought by Woolworths’ development unit Fabcot Pty Ltd,…
Environmental activists claim fracking by natural gas company Tamboran in the Northern Territory’s Beetaloo Basin risks contaminating groundwater.
The heir to a Queensland concrete empire has been granted access to Neilsen Group’s books following a dispute with her brother over the company’s operations that resulted in her appointment as a director.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.
Two High Court cases weighing key issues for class action practitioners will likely push the trial in a shareholder proceeding against the collapsed Blue Sky Alternative Investments and auditor EY to early 2026.
A judge has allowed investors bringing a class action against Virgin to join Velocity Rewards to the case, despite finding the proposed claims against the frequent flyer program are “barely arguable”.
A class action against Virgin Australia wants to drag Velocity Rewards into the case, claiming the frequent flyer program was involved in misleading investors about $460 million in funds on Virgin’s balance sheet.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.